Medicare health plans

Federal judge declines to block Medicare drug price negotiations
Health

Federal judge declines to block Medicare drug price negotiations

A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on Friday declined to block the Biden administration from implementing Medicare drug price negotiations, upholding for now a controversial process that aims to make costly medications […]

Read More
Ozempic could be the next target of Medicare drug price negotiations – here’s why
Health

Ozempic could be the next target of Medicare drug price negotiations – here’s why

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.  George Frey | Reuters Ozempic, the blockbuster diabetes treatment from Novo Nordisk, could be next in line for price negotiations between manufacturers and Medicare.  […]

Read More
Biden administration unveils first 10 drugs subject to Medicare price negotiations
Health

Biden administration unveils first 10 drugs subject to Medicare price negotiations

Kubra Cavus | Istock | Getty Images The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.  President Joe Biden’s Inflation Reduction Act, which passed in a […]

Read More
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
Health

Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data

A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023.  Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical trial – a landmark finding that could put more […]

Read More
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
Health

Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s treatment Leqembi, a major turning point for patients who are diagnosed with the early stages of the disease. Leqembi is the only drug on the […]

Read More
Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit
Health

Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit

Bristol Myers Squibb on Friday sued the Biden administration over Medicare’s new powers to slash drug prices, the third such lawsuit to be filed against the program in a matter of days. The lawsuit, filed in federal district court in New Jersey, argues the Medicare negotiations violate the First and Fifth Amendments of the U.S. […]

Read More
Eli Lilly CEO says Medicare price negotiations could harm drug development
Health

Eli Lilly CEO says Medicare price negotiations could harm drug development

David Ricks, CEO, Eli Lilly. Scott Mlyn | CNBC Eli Lilly CEO David Ricks on Tuesday said Medicare price negotiations, which aim to cut costs for older Americans, could potentially harm drug development.  “I’m really worried about the harm this will do to new cures and possibilities in medicine,” Ricks said in an interview on […]

Read More
Merck sues Biden administration over Medicare drug price negotiations
Health

Merck sues Biden administration over Medicare drug price negotiations

Jakub Porzycki | NurPhoto | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare’s new powers to substantially reduce drug prices for seniors under the Inflation Reduction Act, the opening salvo in the pharmaceutical industry’s efforts to weaken the program. In a scathing complaint filed in federal district court, Merck excoriated […]

Read More
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
Health

Pfizer CEO says Medicare will likely face legal action over drug price negotiations

Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla on Thursday said pharmaceutical companies […]

Read More
Social Safety price tag-of-dwelling adjustment will be 8.7% in 2023, best increase in 40 many years
World

Social Safety price tag-of-dwelling adjustment will be 8.7% in 2023, best increase in 40 many years

Azmanjaka | E+ | Getty Illustrations or photos Amid document large inflation, Social Stability beneficiaries will get an 8.7% boost to their benefits in 2023, the optimum maximize in 40 many years. The Social Security Administration declared the alter on Thursday. It will result in a profit raise of more than $140 extra for every […]

Read More